72,234 articles
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center, also called Cedars of Lebanon-Mount Sinai after its 1961 merger, is a nonprofit academic hospital at 8700 Beverly Blvd, Los Angeles, with 919 licensed beds, tied #1 in California by U.S. News, and official medical provider for the LA28 Olympics.
CEDATA GPGE study
CEDATA-GPGE registry, a pseudonymized German-Austrian patient registry founded 1 July 2004 by the GPGE, documenting diagnosis, treatment, and outcomes in over 6,000 children with Crohn's disease, ulcerative colitis, or unclassified IBD.
Cedazuridine
Cedazuridine (E7727, ASTX727, Inqovi) is an oral cytidine deaminase inhibitor paired with decitabine; FDA approved 2020 for MDS/CMML and, from 2026, AML with venetoclax, giving IV-equivalent decitabine exposure.
Cediranib
Cediranib (AZD2171, RECENTIN, Zemfirza) is an oral VEGFR-1/2/3 tyrosine kinase inhibitor developed by AstraZeneca for solid tumors; it improved PFS in relapsed platinum-sensitive ovarian cancer (ICON6) but its EU marketing application was withdrawn in 2016.
CEDNIK syndrome
CEDNIK syndrome (cerebral dysgenesis, neuropathy, ichthyosis, keratoderma), also proposed as SNAP29-related disorder, is a rare autosomal recessive neurocutaneous disease caused by biallelic SNAP29 loss-of-function variants, with developmental delay, hypotonia, and variable skin and brain findings.
Cedrela
Cedrela (Spanish cedar, Cedrela odorata) is a Neotropical Meliaceae tree genus, sister to Toona in tribe Cedreleae, native Mexico to Argentina, with aromatic timber, CITES Appendix II protection, and Hypsipyla grandella shoot-borer damage.
Cedrela odorata
Cedrela odorata (Spanish cedar, cigar-box cedar) is a Meliaceae timber tree native from Mexico to tropical America, valued for aromatic, insect-repelling wood; IUCN Vulnerable and CITES Appendix II.
Cedric Blanpain
Cédric Blanpain, born 1970 in Belgium, is a physician-scientist and full professor at the Université Libre de Bruxelles known for identifying cancer stem cells in skin and breast cancers.
Cédric Feschotte
Cédric Feschotte is a molecular biologist and geneticist who studies transposable elements, which make up half the human genome, and is the Barbara McClintock Professor at Cornell University.
Cedric Habiyaremye
Cedric Habiyaremye is a Rwandan-born crop scientist who fled the 1994 genocide as a child, earned a doctorate at Washington State University in 2019, and founded QuinoaHub to grow quinoa and other climate-resilient crops across Africa.
Cedric S. Raine
Cedric S. Raine is a British-born neuropathologist who joined Albert Einstein College of Medicine in 1969 and studied how myelin is damaged in multiple sclerosis.
Cedric Smith (geneticist)
Cedric Austen Bardell Smith (1917–2002) was a British geneticist and mathematician at University College London's Galton Laboratory whose 1953 linkage paper shaped human genetics for 40 years.
Cedrus
Cedrus, commonly called the true cedars, is a genus of four evergreen coniferous tree species in the pine family, growing in the Mediterranean region and western Himalayas.
Cedrus atlantica
Cedrus atlantica, Atlas cedar (Arz atlassi), an endangered Pinaceae conifer endemic to Morocco's Atlas and Rif mountains and Algeria's Tell Atlas and Aurès, declining from drought, grazing, and pests; timber and essential-oil source.
Cedrus deodara
Cedrus deodara, the deodar or Himalayan cedar (devadāru), is a Pinaceae conifer native from NE Afghanistan to W Nepal, IUCN Least Concern, a major timber tree, and a key species in Himalayan climate and dendrochronology research.
Cedrus libani
Cedrus libani, the Cedar of Lebanon (أرز لبنان), a Vulnerable evergreen Pinaceae conifer native to southern Türkiye, Lebanon, and Syria, famed for durable ancient timber, montane refugia, and large Turkish reforestation programs.
Cees Dekker
Cees Dekker (Cornelis Dekker, born 1959) is a Dutch physicist and Distinguished University Professor at TU Delft, known for carbon nanotube transistors and single-molecule biophysics of DNA.
Cefaclor anhydrous
Cefaclor anhydrous (Ceclor, Lilly 99638) is the water-free form of cefaclor, an oral second-generation cephalosporin antibiotic derived from cephalexin, FDA-approved in 1979, acting by inhibiting bacterial cell-wall synthesis.
Cefadroxil
Cefadroxil (Duricef) is a first-generation oral cephalosporin antibiotic for urinary tract, skin, and streptococcal pharyngitis infections; its longer half-life than cephalexin allows once- or twice-daily dosing with similar efficacy.
Cefalexin
Cefalexin (cephalexin, Keflex) is a first-generation oral cephalosporin antibiotic, bactericidal via penicillin-binding protein inhibition, dosed 250 mg q6h to 4 g/day, renally excreted unchanged, used for skin, urinary, bone, and respiratory infections.
Cefazolin
Cefazolin (Ancef, Kefzol) is a first-generation parenteral cephalosporin antibiotic derived from cephalosporin C, approved in the U.S. in 1973, used for surgical prophylaxis and MSSA infections, limited by the cefazolin inoculum effect.
Cefdinir
Cefdinir (Omnicef) is an extended-spectrum, third-generation oral cephalosporin antibiotic for mild to moderate infections including otitis media, pneumonia, sinusitis, pharyngitis, and skin infections; renal elimination, half-life 1.7 hours.
Cefepime
Cefepime (Maxipime) is a fourth-generation cephalosporin antibiotic, IV, approved 1996, used for pneumonia, febrile neutropenia, and UTIs; renally cleared, with dose-dependent neurotoxicity risk in renal impairment.
Cefiderocol
Cefiderocol (Fetroja, Fetcroja), formerly S-649266, is Shionogi's siderophore cephalosporin antibiotic using a Trojan horse iron-uptake mechanism against multidrug-resistant Gram-negative bacteria, approved 2019-2020 in the US and EU.
Cefixime
Cefixime (Suprax) is an oral third-generation cephalosporin antibiotic, U.S. approved 1986, used for UTIs, otitis media, bronchitis, and as an 800 mg alternative to ceftriaxone for gonorrhea.
Cefmenoxime
Cefmenoxime (SCE-1365, A-50912) is a third-generation injectable aminothiazolyl cephalosporin antibiotic developed by Takeda, active against Enterobacteriaceae and resistant to beta-lactamases, with an NMTT side chain linked rarely to bleeding and disulfiram-like reactions.
Cefmetazole
Cefmetazole (CS-1170), a semisynthetic cephamycin second-generation cephalosporin antibiotic given parenterally, similar to cefoxitin; marketed in the US as ZEFAZONE (approved 1989, withdrawn 2001) and still used in Asia for ESBL-E infections.
Cefonicid
Cefonicid (Monocid) is a long-acting second-generation cephalosporin antibiotic given IV or IM once daily, with a ~4.5-hour half-life and 98% protein binding; FDA-approved 1984, withdrawn from the US market by 2002.
Ceforanide
Ceforanide (BL-S786, Precef) is a discontinued second-generation cephalosporin antibiotic given intravenously or intramuscularly, with a roughly 3-hour half-life, renal elimination, activity against coliforms and H. influenzae, and no Pseudomonas coverage.
Cefotaxime
Cefotaxime sodium, sold as Claforan, is an injectable third-generation cephalosporin antibiotic, the first of its class to reach the market in Germany in 1980, used for serious gram-negative infections and preferred in neonates.